Stem Bromelain.

Both are cysteine proteases with different residue preferences, so together they cleave a wider range of peptide bonds than either alone. The pairing is the oldest one in plant enzyme formulation.

Bromelain is routinely added to quercetin formulas on the reasoning that the protease raises the fraction of the poorly soluble flavonol taken up from the gut. The combination has been standard practice for decades.

Curcumin is barely soluble and poorly taken up, and bromelain is added in practice on the reasoning that it raises the absorbed fraction. The two are also long-standing partners in botanical comfort formulas.

Boswellic acids act on the 5-lipoxygenase arm of eicosanoid signalling while bromelain acts on kinin and fibrin handling in tissue. Formulators pair them because the mechanisms do not overlap.

Pancreatic-style blends work at intestinal pH while bromelain stays active across a much wider pH range including the stomach. Together they cover protein breakdown from the first compartment onward.

Bromelain handles the protein fraction of a meal and alpha-galactosidase handles the alpha-galactoside sugars in legumes. Neither substrate overlaps, so a blend covers both.

Systemic use of bromelain depends on the enzyme passing the stomach intact, which is why it is enteric coated, while betaine hydrochloride is taken to lower gastric pH. Taken together the acid load pulls against the delivery the coating exists to achieve.

Bromelain has recognised fibrinolytic activity and lowers platelet aggregation, and EPA shifts eicosanoid output toward the less aggregatory series. The two effects on normal clotting add.

Ginkgolide B antagonises platelet-activating factor while bromelain lowers platelet aggregation and supports fibrin breakdown. Both act on the same normal clotting process from different directions.

Garlic organosulfur compounds such as ajoene lower platelet aggregation, an effect that adds to bromelain's own. Worth noting when both appear in one formula.

A 2025 randomised trial gave bromelain together with troxerutin, a semi-synthetic derivative of rutin, and escin to adults recovering from hip or knee joint replacement. The combination was tested as a unit, so the contribution of any single component cannot be separated out. Both bromelain and rutin-type flavonoids are used in swelling and fluid-handling formulas, which is why they are formulated together. Regard this as a formulation-level pairing rather than a demonstrated two-ingredient interaction.

Bromelain and alpha-lipoic acid were given together in a randomised controlled trial in adults recovering from breast conserving surgery. The pair was tested as a fixed combination, so neither component was isolated. Mechanistically they come at tissue recovery from different directions, a protease on one side and a redox-active cofactor analogue on the other. That non-overlap is the rationale, not a measured additive effect.

Pancreatin supplies protease, lipase and amylase activity that works in the small intestine at near-neutral pH. Stem bromelain is a plant cysteine protease that stays active across a wider pH span, including the acidic stomach. Putting them in one capsule covers protein breakdown in both compartments rather than only one. The two do not compete for a shared cofactor.

Pepsin cleaves protein only in a strongly acidic stomach and switches off as pH rises. Bromelain keeps hydrolysing peptide bonds after gastric emptying. Formulators pair them because the activity windows sit next to each other rather than on top of each other. Neither enzyme requires the other to function.

Lipase acts on triglycerides and bromelain acts on peptide bonds, so the two cover different macronutrients in a mixed meal. They are routinely combined for that reason alone. There is no shared substrate and no known interference between them. The pairing is about coverage of the meal, not about one enzyme boosting the other.

Amylase hydrolyses starch and bromelain hydrolyses protein. A blend of the two handles a starch-and-protein meal that neither covers alone. Activity units differ by enzyme class, so a bromelain GDU figure says nothing about the amylase content in the same product. Read each activity number against its own scale.

Lactase splits lactose at the brush border and has no overlap with proteolytic activity. It appears alongside bromelain in general digestive blends aimed at mixed meals. The pairing is additive coverage, not a mechanistic partnership. Lactase is also acid-sensitive, which is why blends often use protective coatings.

Bile acids emulsify fat and raise the surface area available to lipases; they do nothing to peptide bonds. A blend carrying both ox bile and bromelain addresses fat and protein in separate steps of the same meal. There is no competition between them. This is complementary coverage rather than enhancement.

Whey protein is a substrate for proteolytic enzymes, and bromelain hydrolyses it into shorter peptides and free amino acids. Taken with a protein dose, a protease shifts the peptide size distribution reaching the intestine. Whether that changes the amount of amino acid absorbed is a separate question that a hydrolysis experiment does not answer. State it as a digestion step, not as an absorption gain.

Collagen peptides are already partly hydrolysed, and stem bromelain will cleave them further. That reduces average peptide chain length before absorption. Some collagen research is built around specific di- and tripeptides surviving digestion, so a co-dosed protease changes the mixture that arrives. The direction of that change on any downstream measure has not been established.

Bovine colostrum is valued for intact immunoglobulins and growth factors, which are proteins. A supplemental protease taken in the same dose acts on exactly those molecules. Separating a colostrum dose from a proteolytic enzyme dose is the ordinary formulation answer. This is a plausible antagonism from protein chemistry rather than a measured loss of effect.

Both bromelain and nattokinase are described in the literature as acting on fibrin and platelet aggregation pathways. Stacking two agents with the same directional activity may produce a larger combined effect than either alone, though the pair has not been measured together. Anyone already on blood-thinning medication should raise the combination with their prescriber before using it. Flagged here as a possible additive effect worth knowing, not as a benefit.

White willow bark supplies salicin, which the body converts to salicylate, and salicylates reduce platelet aggregation. Bromelain has its own reported activity in the same direction. Taken together they may push further than either alone, which has not been measured for this pair. This is a caution flag for anyone with a bleeding risk or upcoming surgery, and it is worth a prescriber conversation.

Serrapeptase is a bacterial metalloprotease and bromelain is a plant cysteine protease, so the two cleave protein through different catalytic chemistry. They are commonly stacked in systemic enzyme products taken away from food. No head-to-head or combination trial supports the pairing. Regard it as a formulation convention with a mechanistic rationale.

MSM and bromelain appear together in products aimed at joint comfort and mobility after activity. The rationale is that they act through unrelated routes, a sulfur donor alongside a protease. No combination study of these two has been identified. This is a formulation pairing, and the confidence label reflects that.

L-glutamine is a fuel for enterocytes and appears in gut-support blends alongside proteolytic enzymes. Bromelain contributes protein breakdown in the lumen while glutamine acts on the cells lining it. The two do not share a pathway or compete for absorption. No combination evidence has been identified.

Vitamin C is a standard component of recovery formulas that also carry bromelain, because ascorbate is a cofactor for collagen hydroxylation in normal connective tissue turnover. That is a separate pathway from proteolysis. The two are formulated together rather than mechanistically linked. Nothing here implies one improves the other.